J&J | JNJ - Ebitda





Ebitda Alterar Data
AbbVie USD 5.37B 1.85B 2025-12
Abbott USD 2.43B 844M 2026-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Baxter International USD -447M 873M 2025-12
Bayer EUR 4.45B 2.49B 2026-03
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Boston Scientific USD 1.16B 213M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
CONMED USD 56.39M 23.97M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.06B 29.9M 2026-03
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merck USD 6.3B 2.09B 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.31B 3.65B 2026-03
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 939M 101M 2025-12